Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 2 | — | — | — | 6 |
Lymphoma | D008223 | — | C85.9 | 4 | 2 | — | — | — | 6 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 2 | 2 | — | — | — | 4 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 2 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 1 | — | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 3 | — | — | — | — | 3 |
Plasma cell neoplasms | D054219 | — | — | 3 | — | — | — | — | 3 |
B-cell lymphoma | D016393 | — | — | 2 | — | — | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | 1 | — | — | — | — | 1 |
Small cell carcinoma | D018288 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Selicrelumab |
INN | selicrelumab |
Description | CP-870893 (mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109477 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 0O39RGI33V (ChemIDplus, GSRS) |